Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction

Reproductive BioMedicine Online

Volumn 32, Issue 6, 2016, Pages 563-583

  Birch Petersen, Kathrine ^a   Pedersen, Nina Gros ^a   Pedersen, Anette Tønnes ^a   Lauritsen, Mette Petri ^b   la Cour Freiesleben, Nina ^c  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

assisted reproduction; BMI; clomiphene citrate; infertility; PCOS

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN DERIVATIVE; LETROZOLE; METFORMIN; CLOMIFENE; FERTILITY PROMOTING AGENT; GONADOTROPIN; NITRILE; TRIAZOLE DERIVATIVE;

BODY WEIGHT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LIFESTYLE; LIVE BIRTH; MENSTRUAL CYCLE; META ANALYSIS (TOPIC); MULTIPLE PREGNANCY; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); ADULT; ANOVULATION; BLOOD; CHEMISTRY; COMPLICATION; INFERTILITY THERAPY; INFERTILITY, FEMALE; OVULATION; PATIENT SAFETY; POLYCYSTIC OVARY SYNDROME; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; ANOVULATION; BODY WEIGHT; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; LIFE STYLE; METFORMIN; NITRILES; OVERWEIGHT; OVULATION; OVULATION INDUCTION; PATIENT SAFETY; POLYCYSTIC OVARY SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TRIAZOLES;

EID: 84963632359     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2016.03.006     Document Type: Review

References (96)

1. Abu Hashim, H., Foda, O., Ghayaty, E., Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet. Gynecol. Scand 94 (2015), 921–930.
2. Abu Hashim, H., Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach. Arch. Gynecol. Obstet 291 (2015), 11–18.
3. Abuelghar, W.M., Bayoumy, H.A., Ellaithy, M.I., Khalil, M.S., Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling. Eur. J. Obstet. Gynecol. Reprod. Biol 175 (2014), 178–185.
4. Al-Azemi, M., Omu, F.E., Omu, A.E., The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch. Gynecol. Obstet 270 (2004), 205–210.
5. Alebic, M.S., Stojanovic, N., Duhamel, A., Dewailly, D., The phenotypic diversity in per-follicle anti-Mullerian hormone production in polycystic ovary syndrome. Hum. Reprod 30 (2015), 1927–1933.
6. Api, M., Is ovarian reserve diminished after laparoscopic ovarian drilling?. Gynecol. Endocrinol 25 (2009), 159–165.
7. Bayram, N., van Wely, M., Kaaijk, E.M., Bossuyt, P.M., van der Veen, F., Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ, 328, 2004, 192.
8. Bevilacqua, A., Carlomagno, G., Gerli, S., Montanino Oliva, M., Devroey, P., Lanzone, A., Soulange, C., Facchinetti, F., Carlo Di Renzo, G., Bizzarri, M., Hod, M., Cavalli, P., D'Anna, R., Benvenga, S., Chiu, T.T., Kamenov, Z.A., Results from the international consensus conference on myo-inositol and D-chiro-inositol in obstetrics and gynecology–assisted reproduction technology. Gynecol. Endocrinol 31 (2015), 441–446.
9. Calaf Alsina, J., Ruiz Balda, J.A., Romeu Sarrio, A., Caballero Fernandez, V., Cano Trigo, I., Gomez Parga, J.L., Gonzalez Batres, C., Rodriguez Escudero, F.J., Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. BJOG 110 (2003), 1072–1077.
10. Cassina, M., Dona, M., Di Gianantonio, E., Litta, P., Clementi, M., First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum. Reprod. Update 20 (2014), 656–669.
11. Christin-Maitre, S., Hugues, J.N., A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum. Reprod 18 (2003), 1626–1631.
12. Clark, A.M., Thornley, B., Tomlinson, L., Galletley, C., Norman, R.J., Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod 13 (1998), 1502–1505.
13. Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., Pfeifer, M., Pignatelli, D., Pugeat, M., Yildiz, B.O., The polycystic ovary syndrome: a position statement from the European society of endocrinology. Eur. J. Endocrinol 171 (2014), P1–P29.
14. Costello, M.F., Eden, J.A., A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil. Steril 79 (2003), 1–13.
15. Curi, D.D., Fonseca, A.M., Marcondes, J.A., Almeida, J.A., Bagnoli, V.R., Soares, J.M. Jr., Baracat, E.C., Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol. Endocrinol 28 (2012), 182–185.
16. De Frene, V., Gerris, J., Weyers, S., Dhont, M., Vansteelandt, S., Annemans, L., De Sutter, P., Gonadotropin therapy versus laparoscopic ovarian drilling in clomiphene citrate-resistant polycystic ovary syndrome patients: a retrospective cost-effectiveness analysis. Gynecol. Obstet. Invest 80 (2015), 164–169.
17. Deveci, C.D., Demir, B., Sengul, O., Dilbaz, B., Goktolga, U., Clomiphene citrate “stair-step” protocol vs. traditional protocol in patients with polycystic ovary syndrome: a randomized controlled trial. Arch. Gynecol. Obstet 291 (2015), 179–184.
18. Dewailly, D., Gronier, H., Poncelet, E., Robin, G., Leroy, M., Pigny, P., Duhamel, A., Catteau-Jonard, S., Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum. Reprod 26 (2011), 3123–3129.
19. Diamanti-Kandarakis, E., Panidis, D., Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin. Endocrinol. (Oxf) 67 (2007), 735–742.
20. Dickey, R.P., Taylor, S.N., Lu, P.Y., Sartor, B.M., Rye, P.H., Pyrzak, R., Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil. Steril 78 (2002), 1088–1095.
21. Dodge, S.T., Strickler, R.C., Keller, D.W., Ovulation induction with low doses of clomiphene citrate. Obstet. Gynecol 67 (1986), 63S–65S.
22. Domecq, J.P., Prutsky, G., Mullan, R.J., Hazem, A., Sundaresh, V., Elamin, M.B., Phung, O.J., Wang, A., Hoeger, K., Pasquali, R., Erwin, P., Bodde, A., Montori, V.M., Murad, M.H., Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J. Clin. Endocrinol. Metab 98 (2013), 4655–4663.
23. Duijkers, I.J., Klipping, C., Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol. Endocrinol 26 (2010), 152–160.
24. Eijkemans, M.J., Imani, B., Mulders, A.G., Habbema, J.D., Fauser, B.C., High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum. Reprod 18 (2003), 2357–2362.
25. ESHRE, Consensus on infertility treatment related to polycystic ovary syndrome. Hum. Reprod 23 (2008), 462–477.
26. ESHRE Capri Workshop Group. Health and fertility in World Health Organization group 2 anovulatory women. Hum. Reprod. Update 18 (2012), 586–599.
27. ESHRE REA-SPCWG, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod 19 (2004), 41–47.
28. Farquhar, C., Brown, J., Marjoribanks, J., Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst. Rev(6), 2012 CD001122.
29. Farquhar, C.M., Williamson, K., Brown, P.M., Garland, J., An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum. Reprod 19 (2004), 1110–1115.
30. Fernandez, H., Morin-Surruca, M., Torre, A., Faivre, E., Deffieux, X., Gervaise, A., Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. Reprod. Biomed. Online 22 (2011), 556–568.
31. Franik, S., Kremer, J.A., Nelen, W.L., Farquhar, C., Marjoribanks, J., Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a cochrane review. Fertil. Steril 103 (2015), 353–355.
32. Greenblatt, R.B., Barfield, W.E., Jungck, E.C., Ray, A.W., Induction of ovulation with MRL/41. Preliminary report. JAMA 178 (1961), 101–104.
33. Haqq, L., McFarlane, J., Dieberg, G., Smart, N., The effect of lifestyle intervention on body composition, glycaemic control and cardio-respiratory fitness in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Int. J. Sport Nutr. Exerc. Metab 25 (2015), 533–540.
34. Homburg, R., Clomiphene citrate–end of an era? A mini-review. Hum. Reprod 20 (2005), 2043–2051.
35. Homburg, R., Howles, C.M., Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum. Reprod. Update 5 (1999), 493–499.
36. Homburg, R., Hendriks, M.L., Konig, T.E., Anderson, R.A., Balen, A.H., Brincat, M., Child, T., Davies, M., D'Hooghe, T., Martinez, A., Rajkhowa, M., Rueda-Saenz, R., Hompes, P., Lambalk, C.B., Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum. Reprod 27 (2012), 468–473.
37. Imani, B., Eijkemans, M.J., te Velde, E.R., Habbema, J.D., Fauser, B.C., Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab 83 (1998), 2361–2365.
38. Imani, B., Eijkemans, M.J., de Jong, F.H., Payne, N.N., Bouchard, P., Giudice, L.C., Fauser, B.C., Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J. Clin. Endocrinol. Metab 85 (2000), 676–682.
39. Imani, B., Eijkemans, M.J., Faessen, G.H., Bouchard, P., Giudice, L.C., Fauser, B.C., Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil. Steril 77 (2002), 83–90.
40. Johnson, N.P., Stewart, A.W., Falkiner, J., Farquhar, C.M., Milsom, S., Singh, V.P., Okonkwo, Q.L., Buckingham, K.L., PCOSMIC: a multi-centre randomized trial in women with PolyCystic ovary syndrome evaluating metformin for infertility with clomiphene. Hum. Reprod 25 (2010), 1675–1683.
41. Kamenov, Z., Kolarov, G., Gateva, A., Carlomagno, G., Genazzani, A.D., Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol. Endocrinol 31 (2015), 131–135.
42. Kristensen, S.L., Ramlau-Hansen, C.H., Ernst, E., Olsen, S.F., Bonde, J.P., Vested, A., Toft, G., A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?. Hum. Reprod 25 (2010), 3117–3122.
43. Lass, N., Kleber, M., Winkel, K., Wunsch, R., Reinehr, T., Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J. Clin. Endocrinol. Metab 96 (2011), 3533–3540.
44. Lauritsen, M.P., Pinborg, A., Loft, A., Petersen, J.H., Mikkelsen, A.L., Bjerge, M.R., Nyboe Andersen, A., Revised criteria for PCOS in WHO Group II anovulatory infertility – a revival of hypothalamic amenorrhoea?. Clin. Endocrinol. (Oxf) 82 (2015), 584–591.
45. Leader, A., Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone. Fertil. Steril 85 (2006), 1766–1773.
46. Legro, R.S., Barnhart, H.X., Schlaff, W.D., Carr, B.R., Diamond, M.P., Carson, S.A., Steinkampf, M.P., Coutifaris, C., McGovern, P.G., Cataldo, N.A., Gosman, G.G., Nestler, J.E., Giudice, L.C., Leppert, P.C., Myers, E.R., Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med 356 (2007), 551–566.
47. Legro, R.S., Brzyski, R.G., Diamond, M.P., Coutifaris, C., Schlaff, W.D., Casson, P., Christman, G.M., Huang, H., Yan, Q., Alvero, R., Haisenleder, D.J., Barnhart, K.T., Bates, G.W., Usadi, R., Lucidi, S., Baker, V., Trussell, J.C., Krawetz, S.A., Snyder, P., Ohl, D., Santoro, N., Eisenberg, E., Zhang, H., Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N. Engl. J. Med 371 (2014), 119–129.
48. Legro, R.S., Dodson, W.C., Kris-Etherton, P.M., Kunselman, A.R., Stetter, C.M., Williams, N.I., Gnatuk, C.L., Estes, S.J., Fleming, J., Allison, K.C., Sarwer, D.B., Coutifaris, C., Dokras, A., Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab 100 (2015), 4048–4058 jc20152778.
49. Li, R.H., Ng, E.H., Management of anovulatory infertility. Best Pract. Res. Clin. Obstet. Gynaecol 26 (2012), 757–768.
50. Lim, S.S., Davies, M.J., Norman, R.J., Moran, L.J., Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 18 (2012), 618–637.
51. Lobo, R.A., Gysler, M., March, C.M., Goebelsmann, U., Mishell, D.R. Jr., Clinical and laboratory predictors of clomiphene response. Fertil. Steril 37 (1982), 168–174.
52. Lopez, E., Gunby, J., Daya, S., Parrilla, J.J., Abad, L., Balasch, J., Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. Reprod. Biomed. Online 9 (2004), 382–390.
53. Mathur, R., Alexander, C.J., Yano, J., Trivax, B., Azziz, R., Use of metformin in polycystic ovary syndrome. Am. J. Obstet. Gynecol 199 (2008), 596–609.
54. McKnight, K.K., Nodler, J.L., Cooper, J.J. Jr., Chapman, V.R., Cliver, S.P., Bates, G.W. Jr., Body mass index-associated differences in response to ovulation induction with letrozole. Fertil. Steril 96 (2011), 1206–1208.
55. Misso, M.L., Costello, M.F., Garrubba, M., Wong, J., Hart, R., Rombauts, L., Melder, A.M., Norman, R.J., Teede, H.J., Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 19 (2013), 2–11.
56. Moazami Goudarzi, Z., Fallahzadeh, H., Aflatoonian, A., Mirzaei, M., Laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome: a systematic review and meta-analysis. Iran J. Reprod. Med 12 (2014), 531–538.
57. Moolenaar, L.M., Nahuis, M.J., Hompes, P.G., van der Veen, F., Mol, B.W., Cost-effectiveness of treatment strategies in women with PCOS who do not conceive after six cycles of clomiphene citrate. Reprod. Biomed. Online 28 (2014), 606–613.
58. Moran, L.J., Hutchison, S.K., Norman, R.J., Teede, H.J., Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst. Rev, 7, 2011 CD007506.
59. Moran, L.J., Norman, R.J., Teede, H.J., Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol. Metab 26 (2015), 136–143.
60. Morgante, G., Orvieto, R., Di Sabatino, A., Musacchio, M.C., De Leo, V., The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. Fertil. Steril 95 (2011), 2642–2644.
61. Morin-Papunen, L., Rantala, A.S., Unkila-Kallio, L., Tiitinen, A., Hippelainen, M., Perheentupa, A., Tinkanen, H., Bloigu, R., Puukka, K., Ruokonen, A., Tapanainen, J.S., Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J. Clin. Endocrinol. Metab 97 (2012), 1492–1500.
62. Muktabhant, B., Lawrie, T.A., Lumbiganon, P., Laopaiboon, M., Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst. Rev(6), 2015 CD007145.
63. Naderpoor, N., Shorakae, S., de Courten, B., Misso, M.L., Moran, L.J., Teede, H.J., Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum. Reprod. Update 21 (2015), 560–574.
64. Nahuis, M., van der Veen, F., Oosterhuis, J., Mol, B.W., Hompes, P., van Wely, M., Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women. Int. J. Womens Health 1 (2010), 205–211.
65. Nahuis, M.J., Kose, N., Bayram, N., van Dessel, H.J., Braat, D.D., Hamilton, C.J., Hompes, P.G., Bossuyt, P.M., Mol, B.W., van der Veen, F., van Wely, M., Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Hum. Reprod 26 (2011), 1899–1904.
66. Nahuis, M.J., Oude Lohuis, E., Kose, N., Bayram, N., Hompes, P., Oosterhuis, G.J., Kaaijk, E.M., Cohlen, B.J., Bossuyt, P.P., van der Veen, F., Mol, B.W., van Wely, M., Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: an economic evaluation. Hum. Reprod 27 (2012), 3577–3582.
67. Nahuis, M.J., Weiss, N.S., van der Veen, F., Mol, B.W., Hompes, P.G., Oosterhuis, J., Lambalk, N.B., Smeenk, J.M., Koks, C.A., van Golde, R.J., Laven, J.S., Cohlen, B.J., Fleischer, K., Goverde, A.J., Gerards, M.H., Klijn, N.F., Nekrui, L.C., van Rooij, I.A., Hoozemans, D.A., van Wely, M., The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate – a randomised controlled trial. BMC Womens Health, 13, 2013, 42.
68. Norman, R.J., Noakes, M., Wu, R., Davies, M.J., Moran, L., Wang, J.X., Improving reproductive performance in overweight/obese women with effective weight management. Hum. Reprod. Update 10 (2004), 267–280.
69. Nybacka, A., Carlstrom, K., Stahle, A., Nyren, S., Hellstrom, P.M., Hirschberg, A.L., Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome. Fertil. Steril 96 (2011), 1508–1513.
70. Pacchiarotti, A., Carlomagno, G., Antonini, G., Pacchiarotti, A., Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol. Endocrinol 32 (2016), 69–73.
71. Palomba, S., Aromatase inhibitors for ovulation induction. J. Clin. Endocrinol. Metab 100 (2015), 1742–1747.
72. Palomba, S., Orio, F. Jr., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., Zullo, F., Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab 90 (2005), 4068–4074.
73. Palomba, S., Falbo, A., Orio, F. Jr., Zullo, F., Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil. Steril 92 (2009), 1646–1658.
74. Palomba, S., Falbo, A., Giallauria, F., Russo, T., Rocca, M., Tolino, A., Zullo, F., Orio, F., Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Hum. Reprod 25 (2010), 2783–2791.
75. Palomba, S., Falbo, A., La Sala, G.B., Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reprod. Biol. Endocrinol, 12, 2014, 3.
76. Perales-Puchalt, A., Legro, R.S., Ovulation induction in women with polycystic ovary syndrome. Steroids 78 (2013), 767–772.
77. Phillips, B., Ball, C., Sackett, D., Badenoch, D., Straus, S., Haynes, B., Dawes, M., Oxford Centre for Evidence-based Medicine – Levels of Evidence. Oxford Center of Evidence Based Medicine http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/, 2009 accessed 12.11.14.
78. Poder, T.G., He, J., Simard, C., Pasquier, J.C., Willingness to pay for ovulation induction treatment in case of WHO II anovulation: a study using the contingent valuation method. Patient Prefer Adherence 8 (2014), 1337–1346.
79. Ramezanzadeh, F., Nasiri, R., Sarafraz Yazdi, M., Baghrei, M., A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Arch. Gynecol. Obstet 284 (2011), 1029–1034.
80. Ravn, P., Haugen, A.G., Glintborg, D., Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss. Minerva Endocrinol 38 (2013), 59–76.
81. Rostami-Hodjegan, A., Lennard, M.S., Tucker, G.T., Ledger, W.L., Monitoring plasma concentrations to individualize treatment with clomiphene citrate. Fertil. Steril 81 (2004), 1187–1193.
82. Siebert, T.I., Viola, M.I., Steyn, D.W., Kruger, T.F., Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol. Obstet. Invest 73 (2012), 304–313.
83. Sinawat, S., Buppasiri, P., Lumbiganon, P., Pattanittum, P., Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS. Cochrane Database Syst. Rev(10), 2012 CD006226.
84. Sivalingam, V.N., Myers, J., Nicholas, S., Balen, A.H., Crosbie, E.J., Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum. Reprod. Update 20 (2014), 853–868.
85. Tang, T., Lord, J.M., Norman, R.J., Yasmin, E., Balen, A.H., Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev(5), 2012 CD003053.
86. Turan, G.A., Eskicioglu, F., Sivrikoz, O.N., Cengiz, H., Adakan, S., Gur, E.B., Tatar, S., Sahin, N., Yilmaz, O., Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study. Arch. Gynecol. Obstet 292 (2015), 1163–1171.
87. van Wely, M., Bayram, N., van der Veen, F., Bossuyt, P.M., An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum. Reprod 19 (2004), 1741–1745.
88. Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogoy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K.F., Bunford, G., Lund, A., Bjerke, C., Almas, I., Berg, A.H., Danielson, A., Lahmami, G., Carlsen, S.M., Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J. Clin. Endocrinol. Metab 95 (2010), E448–E455.
89. Veltman-Verhulst, S.M., Fauser, B.C., Eijkemans, M.J., High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. Fertil. Steril 98 (2012), 761–768 e1.
90. Weiss, N.S., Nahuis, M., Bayram, N., Mol, B.W., Van der Veen, F., van Wely, M., Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Cochrane Database Syst. Rev(9), 2015 CD010290.
91. Wijeyaratne, C.N., Seneviratne Rde, A., Dahanayake, S., Kumarapeli, V., Palipane, E., Kuruppu, N., Yapa, C., Seneviratne Rde, A., Balen, A.H., Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum. Reprod 26 (2011), 202–213.
92. Wu, C.H., Winkel, C.A., The effect of therapy initiation day on clomiphene citrate therapy. Fertil. Steril 52 (1989), 564–568.
93. Xiao, J., Chen, S., Zhang, C., Chang, S., The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol. Endocrinol 28 (2012), 956–960.
94. Yildirim, B., Sabir, N., Kaleli, B., Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil. Steril 79 (2003), 1358–1364.
95. Yildizhan, R., Adali, E., Kolusari, A., Kurdoglu, M., Yildizhan, B., Sahin, H.G., Kamaci, M., Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone. J. Int. Med. Res 36 (2008), 1197–1204.
96. Zhuo, Z., Wang, A., Yu, H., Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Diabetes Res, 2014, 2014 381231.